These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9704153)

  • 21. Proteomic analysis of the inflamed intestinal mucosa reveals distinctive immune response profiles in Crohn's disease and ulcerative colitis.
    Berndt U; Bartsch S; Philipsen L; Danese S; Wiedenmann B; Dignass AU; Hämmerle M; Sturm A
    J Immunol; 2007 Jul; 179(1):295-304. PubMed ID: 17579049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Constitutive STAT3 activation in intestinal T cells from patients with Crohn's disease.
    Lovato P; Brender C; Agnholt J; Kelsen J; Kaltoft K; Svejgaard A; Eriksen KW; Woetmann A; Ødum N
    J Biol Chem; 2003 May; 278(19):16777-81. PubMed ID: 12615922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti- and proinflammatory cytokines in the pathogenesis of tissue damage in Crohn's disease.
    Hommes DW; van Deventer SJ
    Curr Opin Clin Nutr Metab Care; 2000 May; 3(3):191-5. PubMed ID: 10871234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular immune mechanisms in the pathogenesis of Crohn's disease.
    James SP
    In Vivo; 1988; 2(1):1-7. PubMed ID: 2979807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
    Sartor RB
    Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-18 and Crohn's disease.
    Kanai T; Watanabe M; Okazawa A; Sato T; Hibi T
    Digestion; 2001; 63 Suppl 1():37-42. PubMed ID: 11173908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of intestinal immune system by dietary fat intake: relevance to Crohn's disease.
    Miura S; Tsuzuki Y; Hokari R; Ishii H
    J Gastroenterol Hepatol; 1998 Dec; 13(12):1183-90. PubMed ID: 9918423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokines and mucosal inflammatory response in Crohn's disease.
    van Deventer SJ
    Eur J Surg; 1998 Dec; 164(12):897-901. PubMed ID: 10029384
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunohistological study of T-lymphocytes (total and helper) and B-lymphocytes of the colonic mucosa in children with Crohn's disease and non-specific ulcerative colitis].
    Rodrigues M; Zerbini MC; Barbieri D
    Arq Gastroenterol; 1998; 35(3):223-36. PubMed ID: 10029869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease.
    Cornillie F; Shealy D; D'Haens G; Geboes K; Van Assche G; Ceuppens J; Wagner C; Schaible T; Plevy SE; Targan SR; Rutgeerts P
    Aliment Pharmacol Ther; 2001 Apr; 15(4):463-73. PubMed ID: 11284774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative studies of the colonic in situ expression of intercellular adhesion molecules (ICAM-1, -2, and -3), beta2 integrins (LFA-1, Mac-1, and p150,95), and PECAM-1 in ulcerative colitis and Crohn's disease.
    Vainer B; Nielsen OH; Horn T
    Am J Surg Pathol; 2000 Aug; 24(8):1115-24. PubMed ID: 10935652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-talk between RORγt+ innate lymphoid cells and intestinal macrophages induces mucosal IL-22 production in Crohn's disease.
    Mizuno S; Mikami Y; Kamada N; Handa T; Hayashi A; Sato T; Matsuoka K; Matano M; Ohta Y; Sugita A; Koganei K; Sahara R; Takazoe M; Hisamatsu T; Kanai T
    Inflamm Bowel Dis; 2014 Aug; 20(8):1426-34. PubMed ID: 24991784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacteria in Crohn's disease: mechanisms of inflammation and therapeutic implications.
    Balfour Sartor R
    J Clin Gastroenterol; 2007; 41 Suppl 1():S37-43. PubMed ID: 17438417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current concepts of the pathogenesis of inflammatory bowel disease.
    Shanahan F
    Ir J Med Sci; 1994 Dec; 163(12):544-9. PubMed ID: 7843934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral blood and intestinal lymphocyte sub-populations in Crohn's disease.
    Strickland RG; Husby G; Black WC; Williams RC
    Gut; 1975 Nov; 16(11):847-53. PubMed ID: 1081463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis.
    Boirivant M; Marini M; Di Felice G; Pronio AM; Montesani C; Tersigni R; Strober W
    Gastroenterology; 1999 Mar; 116(3):557-65. PubMed ID: 10029614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gammadelta T Cells in Crohn's Disease: A New Player in the Disease Pathogenesis?
    Catalan-Serra I; Sandvik AK; Bruland T; Andreu-Ballester JC
    J Crohns Colitis; 2017 Sep; 11(9):1135-1145. PubMed ID: 28333360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation and kinetic characteristics of mucosal lymphocytes in Crohn's Disease.
    Clancy R
    Gastroenterology; 1976 Feb; 70(2):177-80. PubMed ID: 1082424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered expression of alpha 4 beta 7, a gut homing integrin, by circulating and mucosal T cells in colonic mucosal inflammation.
    Meenan J; Spaans J; Grool TA; Pals ST; Tytgat GN; van Deventer SJ
    Gut; 1997 Feb; 40(2):241-6. PubMed ID: 9071939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease.
    Danese S; Sans M; Scaldaferri F; Sgambato A; Rutella S; Cittadini A; Piqué JM; Panes J; Katz JA; Gasbarrini A; Fiocchi C
    J Immunol; 2006 Feb; 176(4):2617-24. PubMed ID: 16456024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.